World Prescription Dermatological Drugs Market, 2017 Edition - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "World Prescription Dermatological Drugs Market, 10th Edition" report to their offering.

The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. World Prescription Dermatological Drugs Market takes an inclusive look at many different areas of dermatology and prescription dermatology products.

This area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers -both men and women - for anti aging products, consolidation within the industry, and strong late stage pipeline entities.

World Markets for Prescription Dermatology Product Segments

- Worldwide Market for Prescription Acne and Rosacea Drugs by Type, 2014-2021

- Worldwide Market for Prescription Antiaging and Photodamage Drugs by Type, 2014-2021

- Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type, 2016-2021

- Worldwide Market for Prescription Antifungal Drugs by Type, 2014-2021

- Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type, 2014-2021

- Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type, 2014-2021

- Worldwide Market for Prescription Psoriasis Drugs by Type, 2014-2021

- Worldwide Market for Skin Cancer Drugs by Type, 2014-2021

- Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type, 2014-2021

Key Topics Covered:

1: Executive Summary

2: Introduction And Overview

3: Issues And Trends

4: Prescription Antiacne And Rosacea Drugs

5: Prescription Antiaging And Photodamage Drugs

6: Prescription Dermatitis And Seborrhea Drugs

7: Prescription Antifungal Drugs

8: Prescription Hair Loss And Hair Removal Drugs

9: Prescription Hyperpigmentation/Melasma And Depigmenting Drugs

10: Prescription Psoriasis Drugs

11: Prescription Skin Cancer Drugs

12: Miscellaneous Skin Disorder Drugs

13: World Market Summary

Companies Mentioned

  • AbbVie, Inc.
  • Allergan
  • Almirall, S.A.
  • Amgen, Inc.
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma, Inc.
  • Basilea Pharmaceutica Ltd.
  • Bayer
  • Biofrontera AG
  • Bristol-Myers Squibb
  • Cipher Pharmaceuticals
  • Cutanea Life Sciences
  • Dermira, Inc.
  • Galderma S.A.
  • Genentech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LEO Pharma A/S
  • Maruho Co. Ltd.
  • Merck & Company
  • Merz Pharma GmbH & Co KGaA
  • Mylan N.V.
  • Novan, Inc.
  • Novartis Pharmaceuticals Corporation
  • Pfizer, Inc.
  • PharmaDerm
  • Sienna Biopharmaceuticals, Inc.
  • Sinclair Pharma Plc.
  • Stiefel
  • Valeant Pharmaceuticals International

For more information about this report visit https://www.researchandmarkets.com/research/rkmpw7/world

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs